Literature DB >> 22209877

Valosin containing protein (VCP) interacts with macrolide antibiotics without mediating their anti-inflammatory activities.

Krunoslav Nujić1, Marjorie Smith, Michael Lee, Daniela Belamarić, Linda Tomašković, Sulejman Alihodžić, Ivica Malnar, Denis Polančec, Klaus Schneider, Vesna Eraković Haber.   

Abstract

In addition to antibacterial activity, some macrolide antibiotics, such as azithromycin and clarithromycin, also exhibit anti-inflammatory properties in vitro and in vivo, although the targets and mechanism(s) of action remain unknown. The aim of the present study was to identify protein targets of azithromycin and clarithromycin which could potentially explain their anti-inflammatory effects. Using chemical proteomics approach, based on compound-immobilized affinity chromatography, valosin containing protein (VCP) was identified as a potential target of the macrolides. Validation studies confirmed the interaction of macrolides and VCP and gave some structural characteristics of this interaction. Cell based assays however, including the use of gene silencing and the study of VCP specific cellular functions in J774.A1 (murine macrophage) and IB3-1 (human cystic fibrotic epithelial) cell lines, failed to confirm an association between the binding of the macrolides to VCP and anti-inflammatory effects. These findings suggest the absence of an abundant high affinity protein target and the potential involvement of other biological molecules in the anti-inflammatory activity of macrolides.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22209877     DOI: 10.1016/j.ejphar.2011.12.022

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Structure and conformational analysis of spiroketals from 6-O-methyl-9(E)-hydroxyiminoerythronolide A.

Authors:  Ana Čikoš; Irena Ćaleta; Dinko Žiher; Mark B Vine; Ivaylo J Elenkov; Marko Dukši; Dubravka Gembarovski; Marina Ilijaš; Snježana Dragojević; Ivica Malnar; Sulejman Alihodžić
Journal:  Beilstein J Org Chem       Date:  2015-08-19       Impact factor: 2.883

2.  Macrolides sensitize EGFR-TKI-induced non-apoptotic cell death via blocking autophagy flux in pancreatic cancer cell lines.

Authors:  Shuntaro Mukai; Shota Moriya; Masaki Hiramoto; Hiromi Kazama; Hiroko Kokuba; Xiao-Fang Che; Tomohisa Yokoyama; Satoshi Sakamoto; Akihiro Sugawara; Toshiaki Sunazuka; Satoshi Ōmura; Hiroshi Handa; Takao Itoi; Keisuke Miyazawa
Journal:  Int J Oncol       Date:  2015-11-09       Impact factor: 5.650

3.  Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines.

Authors:  Kazuhiro Hirasawa; Shota Moriya; Kana Miyahara; Hiromi Kazama; Ayako Hirota; Jun Takemura; Akihisa Abe; Masato Inazu; Masaki Hiramoto; Kiyoaki Tsukahara; Keisuke Miyazawa
Journal:  PLoS One       Date:  2016-12-15       Impact factor: 3.240

4.  Macrolide derivatives reduce proinflammatory macrophage activation and macrophage-mediated neurotoxicity.

Authors:  Bei Zhang; Timothy J Kopper; Xiaodong Liu; Zheng Cui; Steven G Van Lanen; John C Gensel
Journal:  CNS Neurosci Ther       Date:  2019-01-24       Impact factor: 5.243

5.  Azithromycin Affords Neuroprotection in Rat Undergone Transient Focal Cerebral Ischemia.

Authors:  Diana Amantea; Francesco Petrelli; Rosaria Greco; Cristina Tassorelli; Maria Tiziana Corasaniti; Paolo Tonin; Giacinto Bagetta
Journal:  Front Neurosci       Date:  2019-11-26       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.